Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 23.2B | 20.0B | 21.2B | 24.8B |
Cost of revenue | 13.4B | 11.3B | 11.9B | 14.1B |
Gross profit | 9.8B | 8.7B | 9.3B | 10.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 6.0B | 5.6B | 5.3B | 6.0B |
Operating income | 1.3B | 801.4M | 1.7B | 2.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 58.8M | 32M | 21.9M | 15.9M |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 613.2M | 1.8B | 2.3B |
Tax provision | 343.1M | 228M | 459.5M | 596.4M |
Net income | 977.6M | 385.2M | 1.3B | 1.7B |
Basic EPS | — | 1.5 | 5 | 6.6 |
Diluted EPS | — | 1.5 | 5 | 6.6 |
Basic average shares | — | 264.8M | 264.3M | 264.6M |
Diluted average shares | — | 264.8M | 264.3M | 264.6M |
EBITDA | 1.9B | 1.5B | 2.4B | 2.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.9M | -1.2M | -1.6M | -2.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |